You have free access to this content

Hepatology

Cover image for Vol. 60 Issue 2

August 2014

Volume 60, Issue 2

Pages 445–771

  1. Hepatology Highlights

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Hepatology highlights (pages 445–447)

      Jean-François Dufour

      Version of Record online: 22 JUL 2014 | DOI: 10.1002/hep.27270

  2. Editorials

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
    2. You have free access to this content
      WNT/β-catenin signaling and hepatocellular carcinoma (pages 452–454)

      Jack R. Wands and Miran Kim

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.27081

    3. You have free access to this content
    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      How does coffee prevent liver fibrosis? biological plausibility for recent epidemiological observations (pages 464–467)

      Jonathan A. Dranoff, Jordan J. Feld, Élise G. Lavoie and Michel Fausther

      Version of Record online: 27 MAY 2014 | DOI: 10.1002/hep.27032

  3. Viral Hepatitis

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have full text access to this OnlineOpen article
    2. You have free access to this content
      Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients (pages 477–486)

      Ashwin Balagopal, Abraham J. Kandathil, Yvonne H. Higgins, Jonathan Wood, Justin Richer, Jeffrey Quinn, Lois Eldred, Zhiping Li, Stuart C. Ray, Mark S. Sulkowski and David L. Thomas

      Version of Record online: 14 MAY 2014 | DOI: 10.1002/hep.27158

    3. You have free access to this content
      Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection (pages 487–496)

      Antonio Riva, Melissa Laird, Armanda Casrouge, Arvydas Ambrozaitis, Roger Williams, Nikolai V. Naoumov, Matthew L. Albert and Shilpa Chokshi

      Version of Record online: 19 MAY 2014 | DOI: 10.1002/hep.27139

    4. You have free access to this content
      Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: Virological and clinical implications (pages 497–507)

      Anders Boyd, Joël Gozlan, Sarah Maylin, Constance Delaugerre, Gilles Peytavin, Pierre-Marie Girard, Fabien Zoulim and Karine Lacombe

      Version of Record online: 20 JUN 2014 | DOI: 10.1002/hep.27182

    5. You have free access to this content
      Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles (pages 508–520)

      Juliane Doerrbecker, Martina Friesland, Nina Riebesehl, Corinne Ginkel, Patrick Behrendt, Richard J.P. Brown, Sandra Ciesek, Heiner Wedemeyer, Christoph Sarrazin, Lars Kaderali, Thomas Pietschmann and Eike Steinmann

      Version of Record online: 24 JUN 2014 | DOI: 10.1002/hep.27190

    6. You have free access to this content
      Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C (pages 521–530)

      Konstantin Kazankov, Francisco Barrera, Holger Jon Møller, Bo Martin Bibby, Hendrik Vilstrup, Jacob George and Henning Grønbæk

      Version of Record online: 6 MAY 2014 | DOI: 10.1002/hep.27129

  4. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have full text access to this OnlineOpen article
      Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice (pages 531–544)

      Irene Locatelli, Salvatore Sutti, Aastha Jindal, Marco Vacchiano, Cristina Bozzola, Chris Reutelingsperger, Dennis Kusters, Stefania Bena, Maurizio Parola, Claudia Paternostro, Elisabetta Bugianesi, Simon McArthur, Emanuele Albano and Mauro Perretti

      Version of Record online: 12 MAY 2014 | DOI: 10.1002/hep.27141

    2. You have full text access to this OnlineOpen article
      Hypercaloric diets with increased meal frequency, but not meal size, increase intrahepatic triglycerides: A randomized controlled trial (pages 545–553)

      Karin E. Koopman, Matthan W.A. Caan, Aart J. Nederveen, Anouk Pels, Mariette T. Ackermans, Eric Fliers, Susanne E. la Fleur and Mireille J. Serlie

      Version of Record online: 13 MAY 2014 | DOI: 10.1002/hep.27149

    3. You have free access to this content
      Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia (pages 554–564)

      Raymond Ng, Heng Wu, Hong Xiao, Xin Chen, Holger Willenbring, Clifford J. Steer and Guisheng Song

      Version of Record online: 19 MAY 2014 | DOI: 10.1002/hep.27153

    4. You have free access to this content
  5. Hepatobiliary Malignancies

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy (pages 576–587)

      Wei Gao, Heungnam Kim, Mingqian Feng, Yen Phung, Charles P. Xavier, Jeffrey S. Rubin and Mitchell Ho

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26996

    2. You have free access to this content
      Index-based dietary patterns and risk of incident hepatocellular carcinoma and mortality from chronic liver disease in a prospective study (pages 588–597)

      Wen-Qing Li, Yikyung Park, Katherine A. McGlynn, Albert R. Hollenbeck, Philip R. Taylor, Alisa M. Goldstein and Neal D. Freedman

      Version of Record online: 20 MAY 2014 | DOI: 10.1002/hep.27160

    3. You have free access to this content
      Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression (pages 598–609)

      Dong-liang Chen, Zhi-qiang Wang, Zhao-lei Zeng, Wen-jing Wu, Dong-sheng Zhang, Hui-yan Luo, Feng Wang, Miao-zhen Qiu, De-shen Wang, Chao Ren, Feng-hua Wang, Lucia J. Chiao, Helene Pelicano, Peng Huang, Yu-hong Li and Rui-hua Xu

      Version of Record online: 28 MAY 2014 | DOI: 10.1002/hep.27118

  6. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Phosphorylation of ABCB4 impacts its function: Insights from disease-causing mutations (pages 610–621)

      Julien Gautherot, Danièle Delautier, Marie-Anne Maubert, Tounsia Aït-Slimane, Gérard Bolbach, Jean-Louis Delaunay, Anne-Marie Durand-Schneider, Delphine Firrincieli, Véronique Barbu, Nicolas Chignard, Chantal Housset, Michèle Maurice and Thomas Falguières

      Version of Record online: 19 MAY 2014 | DOI: 10.1002/hep.27170

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury (pages 622–632)

      Justin M. Belcher, Arun J. Sanyal, Aldo J. Peixoto, Mark A. Perazella, Joseph Lim, Heather Thiessen-Philbrook, Naheed Ansari, Steven G. Coca, Guadalupe Garcia-Tsao, Chirag R. Parikh and for the TRIBE-AKI Consortium

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.26980

    2. You have free access to this content
      Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats (pages 633–647)

      Laura Coch, Marc Mejias, Annalisa Berzigotti, Ester Garcia-Pras, Javier Gallego, Jaime Bosch, Raul Mendez and Mercedes Fernandez

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26995

    3. You have free access to this content
      Bioactive compound reveals a novel function for ribosomal protein S5 in hepatic stellate cell activation and hepatic fibrosis (pages 648–660)

      Wei-Heng Xu, Hong-Gang Hu, Yuan Tian, Shao-Zhan Wang, Jie Li, Jian-Zhong Li, Xing Deng, Hui Qian, Lei Qiu, Zhen-Lin Hu, Qiu-Ye Wu, Yi-Feng Chai, Cheng Guo, Wei-Fen Xie and Jun-Ping Zhang

      Version of Record online: 9 MAY 2014 | DOI: 10.1002/hep.27138

    4. You have free access to this content
      Coffee, alcohol and other beverages in relation to cirrhosis mortality: The Singapore Chinese Health Study (pages 661–669)

      George Boon-Bee Goh, Wan-Cheng Chow, Renwei Wang, Jian-Min Yuan and Woon-Puay Koh

      Version of Record online: 24 JUN 2014 | DOI: 10.1002/hep.27054

  8. Liver Injury/Regeneration

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis (pages 670–678)

      Ulrike A. Köhler, Svitlana Kurinna, Dominik Schwitter, Andrea Marti, Matthias Schäfer, Claus Hellerbrand, Tobias Speicher and Sabine Werner

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26964

    2. You have free access to this content
      Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network (pages 679–686)

      Mark W. Russo, Jay H. Hoofnagle, Jiezhun Gu, Robert J. Fontana, Huiman Barnhart, David E. Kleiner, Naga Chalasani and Herbert L. Bonkovsky

      Version of Record online: 13 MAY 2014 | DOI: 10.1002/hep.27157

    3. You have free access to this content
      Caveolin-1 is essential for protecting against binge drinking-induced liver damage through inhibiting reactive nitrogen species (pages 687–699)

      Lei Gao, Yingchun Zhou, Weichao Zhong, Xiaohua Zhao, Chun Chen, Xingmiao Chen, Yong Gu, Jianping Chen, Zhiping Lv and Jiangang Shen

      Version of Record online: 19 MAY 2014 | DOI: 10.1002/hep.27162

    4. You have full text access to this OnlineOpen article
      Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells (pages 700–714)

      Noushin Dianat, Hélène Dubois-Pot-Schneider, Clara Steichen, Christophe Desterke, Philippe Leclerc, Aurélien Raveux, Laurent Combettes, Anne Weber, Anne Corlu and Anne Dubart-Kupperschmitt

      Version of Record online: 20 JUN 2014 | DOI: 10.1002/hep.27165

  9. AASLD Practice Guideline

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver (pages 715–735)

      Hendrik Vilstrup, Piero Amodio, Jasmohan Bajaj, Juan Cordoba, Peter Ferenci, Kevin D. Mullen, Karin Weissenborn and Philip Wong

      Version of Record online: 8 JUL 2014 | DOI: 10.1002/hep.27210

  10. New Horizons

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Systems biology for hepatologists (pages 736–743)

      José M. Mato, M. Luz Martínez-Chantar and Shelly C. Lu

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.27023

    2. You have free access to this content
      Long noncoding RNA in liver diseases (pages 744–753)

      Kenji Takahashi, Irene Yan, Hiroaki Haga and Tushar Patel

      Version of Record online: 20 JUN 2014 | DOI: 10.1002/hep.27043

  11. Hepatology Elsewhere

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Integrins, myofibroblasts, and organ fibrosis (pages 756–758)

      Michel Fausther and Jonathan A. Dranoff

      Version of Record online: 9 MAY 2014 | DOI: 10.1002/hep.27155

  12. Clinical Observations in Hepatology

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Intestinal lymphangiectasia and reversible high liver stiffness (pages 759–761)

      Laura Milazzo, Anna Maria Peri, Lucia Lodi, Guido Gubertini, Anna Lisa Ridolfo and Spinello Antinori

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.27025

  13. Correspondence

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
      Noninvasive diagnosis of portal hypertension and esophageal varices through the identification of liver blood flow markers (page 762)

      Andrea Lisotti, Francesco Azzaroli, Marco Montagnani and Giuseppe Mazzella

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26897

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Reply (page 764)

      Yasuhiro Asahina, Kaoru Tsuchiya and Namiki Izumi

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.27066

    5. You have free access to this content
    6. You have free access to this content
    7. You have free access to this content
      Reply (pages 766–767)

      Chiun Hsu, Pei-Jer Chen and Ann-Lii Cheng

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26961

    8. You have free access to this content
    9. You have free access to this content
      Reply (pages 767–768)

      Natasha T. Snider and M. Bishr Omary

      Version of Record online: 18 JUN 2014 | DOI: 10.1002/hep.26952

    10. You have free access to this content
      Vitamin D levels in patients with chronic hepatitis B (page 768)

      Cumali Efe, Tugrul Purnak and Ersan Ozaslan

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.26962

    11. You have free access to this content
      Trends in hepatitis C treatment uptake in the United States (pages 768–769)

      Paul J. Clark, Alexander J. Thompson, Keyur Patel, Andrew J. Muir and Michael L. Volk

      Version of Record online: 26 JUN 2014 | DOI: 10.1002/hep.27213

  14. Corrections

    1. Top of page
    2. Hepatology Highlights
    3. Editorials
    4. Viral Hepatitis
    5. Steatohepatitis/Metabolic Liver Disease
    6. Hepatobiliary Malignancies
    7. Autoimmune, Cholestatic and Biliary Disease
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Injury/Regeneration
    10. AASLD Practice Guideline
    11. New Horizons
    12. Hepatology Elsewhere
    13. Clinical Observations in Hepatology
    14. Correspondence
    15. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content

SEARCH

SEARCH BY CITATION